Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation

S. Ion Gabriel, A. Teodorescu, D. Iulian Dan, A. Maria (Bucharest, Campulung Muscel, Galati, Romania)

Source: Annual Congress 2011 - Clinical parameters in airway diseases
Session: Clinical parameters in airway diseases
Session type: Thematic Poster Session
Number: 949
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Ion Gabriel, A. Teodorescu, D. Iulian Dan, A. Maria (Bucharest, Campulung Muscel, Galati, Romania). Who win? Spirometry versus symptoms for predicting the longitudinal outcomes in COPD patients – 10 years observation. Eur Respir J 2011; 38: Suppl. 55, 949

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
COPD comorbidities – Do they add more cost? A 1-year follow-up study
Source: Annual Congress 2012 - Healthcare utilisation and treatment of asthma and COPD
Year: 2012


Symptoms experienced by COPD patients during exacerbations and their association with healthcare utilization – EXACO study
Source: Annual Congress 2011 - Respiratory epidemiology: quality of life, therapy and socioeconomics
Year: 2011

Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013

Multidimensional problem assessment of asthma and COPD in an older population: patient – physician concordance
Source: Annual Congress 2009 - Oxygen, end-of-life and care for chronic respiratory patients
Year: 2009


Lung function evaluation and patients’ satisfaction with Elpenhaler® device in Greek COPD patients with =1 comorbidity versus patients without comorbidities-AEOLOS study.
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020


Psychological comorbidities in patients with COPD: Which changes can be observed after 3, 6, 9 and 12 months of an inpatient pulmonary rehabilitation (PR)?
Source: International Congress 2015 – Latest insights into the management of chronic respiratory diseases
Year: 2015


BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD – a cross-sectional study
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Chronic lung disease of prematurity: 10 years follow-up using clinical parameters and MR imaging – initial results
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Poorer quality of life in asthma patients is associated with rhinosinusitis, smoking and decreased lung function – Results from the Swedish GA2LEN survey
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012


Cognitive function of patients with COPD after virtual admission – A randomized clinical trial
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012


Direct cost analysis of COPD patients: A 1 year follow-up study
Source: International Congress 2016 – Novel avenues in the treatment of COPD II
Year: 2016


Outcomes in patients with COPD during a 3 year follow-up
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015


Managing asthma in the outpatient clinic – Can the FEV1/FVC indicate when to do a reversibility test?
Source: Annual Congress 2012 - Lung function tests in monitoring airway diseases
Year: 2012

Patients’ adherence to treatment: How does it changes in 1 year after finishing of the participation in trial?
Source: Annual Congress 2013 –New treatments and old dilemmas in the clinical management of lung diseases
Year: 2013

Late Breaking Abstract - Danirixin (GSK1325756) improves respiratory symptoms and health status in mild to moderate COPD – results of a 1 year first time in patient study
Source: International Congress 2017 – Primary care management of respiratory symptoms, allergies, inhalers and adherence
Year: 2017

Stability of severe asthma phenotype – 1 year follow up BIOAIR study
Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Year: 2010


Breathlessness on bending down in COPD patients – prevalence and predictors
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009

Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Predictors of PAO2 and PaCO2 in COPD patients
Source: Annual Congress 2009 - Gas exchange and exercise in respiratory diseases
Year: 2009

The journey to severe obstructive lung disease – Retrospective study of FEV1 decline
Source: Annual Congress 2012 - COPD monitoring in stable disease and during exacerbation
Year: 2012